News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Boxer Capital, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 2% stake in Milestone Pharmaceuticals Inc. |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 4.6% stake in IDEAYA, Inc. |
| 02/14/2023 |
SC 13G/A
| Boxer Capital, LLC reports a 6.9% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 7.5% stake in Milestone Pharmaceuticals Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 7.2% stake in Atreca, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in MATINAS BIOPHARMA HOLDINGS, INC. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC has filed a Schedule 13D for Mereo Biopharma Group plc |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 4.7% stake in SOLID BIOSCIENCES INC. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 1.9% stake in Cabaletta Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 1.9% stake in DBV Technologies S.A. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in SILVERBACK THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in CYMABAY THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 3.8% stake in Elevation Oncology, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in F-Star Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 2.8% stake in POINT Biopharma Global Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 6.3% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in TALIS BIOMEDICAL CORPORATION |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 4.1% stake in Biomea Fusion, Inc. |
| 02/14/2022 |
SC 13G/A
| Boxer Capital, LLC reports a 4.4% stake in Merus N.V. |
| 02/16/2021 |
SC 13G/A
| Boxer Capital, LLC reports a 6.7% stake in Cabaletta Bio, Inc. |
| 02/16/2021 |
SC 13G/A
| Boxer Capital, LLC reports a 0% stake in Trillium Therapeutics Inc. |
| 02/16/2021 |
SC 13G/A
| Boxer Capital, LLC reports a 9.9% stake in SOLID BIOSCIENCES INC. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Boxer Capital, LLC reports a 8.3% stake in Milestone Pharmaceuticals Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Boxer Capital, LLC reports a 5% stake in Syndax Pharmaceuticals, Inc. |
| 12/18/2020 |
SC 13G/A
| Boxer Capital, LLC reports a 4.8% stake in Silverback Therapeutics, Inc. |
|
|
|